Menopause, Misconception, and Health Risk: Aligning Public Understanding with Verified Evidence
This article is not an attempt to replace experience, but to anchor it to place what is felt within what is known, and to ensure that what is known is accurate, verifiable, and responsibly interpreted. Drawing only from sources that can be directly traced and confirmed, including the World Health Organization, North American Menopause Society, American Heart Association, and the Massachusetts General Hospital Center for Women's Mental Health, this discussion seeks to restore alignment between belief and evidence. Because the greatest risk in menopause is not the transition itself, but the misinterpretation of it.
Menopause is a biological transition that is widely experienced but often misunderstood. Much of this misunderstanding arises from the reliance on generalized experiences and outdated interpretations rather than current, verifiable clinical evidence. As a result, symptoms are frequently misclassified, treatment options are avoided, and health risks are either minimized or exaggerated. This article aims to correct these misunderstandings by grounding each discussion in clearly traceable and credible sources, ensuring that claims are aligned with what established authorities actually state.
Misinterpretation of Menopause in Public Discourse
Menopause is one of the few health transitions where personal narratives often carry more authority than clinical guidance. A woman hears that sleepless nights are “normal,” that sudden emotional shifts are “just part of it,” or that treatment options are “too risky to consider.” These statements are not malicious; they are inherited. But when repeated often enough, they begin to function as truth.
In common discourse, menopause is often framed as a uniform experience. Symptoms such as sleep disturbance, mood changes, and vasomotor events are frequently described as inevitable and untreatable. However, this perspective does not reflect current clinical guidance.
Yet, when examined against verified sources, these generalized assumptions begin to unravel. The North American Menopause Society (2022), for instance, does not describe menopause as a condition to be passively endured. Instead, it outlines a framework of individualized care, particularly in relation to hormone therapy, emphasizing that treatment decisions depend on timing, health profile, and symptom severity, not on universal fear. The persistence of caution, therefore, is not rooted in current evidence, but in outdated interpretations that continue to circulate unchallenged.
The persistence of generalized beliefs indicates a gap between clinical consensus and public understanding, where outdated information continues to influence decision-making.
Reassessment of Vasomotor Symptoms
What is often dismissed as inconvenience may, in fact, be communication. Vasomotor symptoms, including hot flashes and night sweats, are commonly treated as minor discomforts to tolerate rather than examine. Mood changes during menopause are often interpreted as behavioral or emotional responses.
However, clinical sources indicate a physiological basis for these changes, findings associated with the American Heart Association reveal a more complex relationship: frequent vasomotor symptoms have been linked to an increased risk of cardiovascular events (Thurston et al., 2021).
This does not mean that every hot flash signals disease, but it does challenge the assumption that such symptoms are insignificant. Instead, they may represent early signals within a broader physiological context, signals that are too often overlooked because they are expected.
Image
Psychological Health During Menopause
Equally misunderstood are the psychological shifts that accompany menopause. Mood changes are frequently interpreted as emotional instability, a narrative that subtly places responsibility on the individual rather than the biology.
Yet the Massachusetts General Hospital Center for Women's Mental Health presents a different perspective: hormonal fluctuations during the menopausal transition can increase vulnerability to depressive symptoms, particularly in those with prior history.
This reframing is important. It moves the conversation from judgment to understanding, from “why am I feeling this way?” to “what is happening physiologically that explains this?” In doing so, it opens the door to appropriate recognition and care, rather than silent endurance.
Positioning Menopause Within Ageing
To understand menopause clearly, it must also be placed correctly. The World Health Organization situates midlife within the broader trajectory of ageing, a phase characterized by increasing susceptibility to chronic conditions and functional change.
However, this perspective requires careful interpretation. Menopause is not defined by the WHO as the cause of all systemic decline, but rather as a transition that occurs within an already evolving biological landscape.
This distinction matters. Without it, menopause becomes a catch-all explanation for every change, obscuring other contributing factors and leading to overgeneralization. With it, menopause is understood more precisely as one element within a complex and dynamic process.
Structural Gaps: What We Know, and What Remains Unclear
Analysis of verified sources reveals several structural limitations in the current understanding of menopause. First, accessible evidence is largely domain-specific, with separate bodies of knowledge addressing cardiovascular risk, mental health, and clinical treatment, rather than presenting menopause as a fully integrated, multidimensional transition. This results in a fragmented evidence landscape, where each domain offers clarity in isolation but lacks a unified framework.
Second, a knowledge translation gap persists. While clinical guidance, such as that from the North American Menopause Society, has evolved toward individualized and evidence-based care, these updates are not consistently reflected in public understanding. As a result, generalized assumptions and outdated interpretations continue to influence decision-making.
Third, an accessibility constraint shapes the available evidence base. Many comprehensive and integrative studies remain behind paywalls or within restricted databases, limiting their use in openly verifiable research. Consequently, reliance on institutional sources, such as those from the American Heart Association and the Massachusetts General Hospital Center for Women's Mental Health becomes necessary.
While these sources are credible and authoritative, they often provide summarized insights rather than full analytical depth. All together, these limitations do not indicate a lack of knowledge, but rather a structural dispersion of knowledge across disciplines, levels of access, and modes of communication. This dispersion contributes to a disconnect between what is clinically established and what is publicly understood.
Conclusion: Reclaiming Understanding
The central problem identified in this discussion is not a lack of information on menopause, but a misalignment between verified clinical evidence and commonly held beliefs. This misalignment is reinforced by three structural issues: fragmented knowledge across disciplines, weak translation of clinical guidance into public understanding, and limited access to comprehensive research. As a result, menopause is often interpreted through assumption rather than evidence, leading to delayed care, unnecessary fear, and under-recognition of clinically relevant symptoms.
Correcting this requires a shift in how information is sourced and applied. First, menopause must be understood through credible authorities, including the World Health Organization, North American Menopause Society, American Heart Association, and the Massachusetts General Hospital Center for Women's Mental Health. These institutions provide structured, evidence-based guidance that clarifies risks, symptoms, and treatment options without overgeneralization. Second, this information must be translated beyond clinical settings into language that is accessible to families and communities, not only healthcare professionals.
Improvement, therefore, is not only clinical but social. When accurate information is consistently applied, menopause shifts from being misunderstood and minimized to being recognized as a legitimate life transition requiring support. This recognition extends beyond the individual to the family and society, where understanding replaces assumption, and support replaces dismissal.
Image
Suggestion Citation
Lendez, M (2026). Menopause and Misinterpretion. Chikicha. (Lendez, M. developer of Ikigai-Bayanihan Framework).
About the Author
Written by Dr. Mariza Lendez, the developer of Ikigai-Bayanihan Framework, a model that redefines aging through purpose, dignity, and community -centered living.
References
American Heart Association (2021) Menopausal vasomotor symptoms and risk of incident cardiovascular disease events in SWAN. Available at: https://www.ahajournals.org/doi/10.1161/JAHA.120.017416
Massachusetts General Hospital Center for Women’s Mental Health (n.d.) Menopause and Mood. Available at: https://womensmentalhealth.org/specialty-clinics/menopause/
North American Menopause Society (2022) The 2022 hormone therapy position statement of The North American Menopause Society. Available at: https://journals.lww.com/menopausejournal/abstract/2022/07000/the_2022_hormone_therapy_position_statement_of_the.4.aspx
World Health Organization (2021) Ageing and health. Available at: https://www.who.int/news-room/fact-sheets/detail/ageing-and-health
